Injectable Agents for Facial Rejuvenation: Botulinum Toxin and Dermal Filling Agents

International Ophthalmology Clinics

Volumn 44, Issue 1, 2004, Pages 189-212

  Mandeville, John T H ^a   Rubin, Peter A D ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; MUSCLE RELAXANT AGENT;

ACCOMMODATION PARALYSIS; AGING; BLEEDING; BLEPHAROSPASM; BLINDNESS; CONFERENCE PAPER; CUTANEOUS PARAMETERS; DIPLOPIA; ECCHYMOSIS; ECTROPION; EDEMA; ENTROPION; EPIPHORA; ERYTHEMA; ESTHETIC SURGERY; EYELID REFLEX; FACE MUSCLE; FACIAL EXPRESSION; FEVER; FLU LIKE SYNDROME; HEADACHE; HUMAN; INJECTION PAIN; INNERVATION; LAGOPHTHALMOS; MALAISE; METHODOLOGY; MUSCLE DENERVATION; MYDRIASIS; NECROTIZING FASCIITIS; PHARMACODYNAMICS; PRION DISEASE; PRIORITY JOURNAL; PROSTHESES AND ORTHOSES; PTOSIS; REJUVENATION; RHYTIDOPLASTY; STRABISMUS;

BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; FACIAL EXPRESSION; FACIAL MUSCLES; HUMANS; MUSCLE DENERVATION; NEUROMUSCULAR AGENTS; PROSTHESES AND IMPLANTS; REJUVENATION; RHYTIDOPLASTY; SKIN AGING;

EID: 0842267787     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-200404410-00018     Document Type: Conference Paper

References (48)

1. Goulding MR, Rogers ME. Trends in aging - United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003;52:101-104, 106.
2. Zimbler MS, Kokoska MS, Thomas JR. Anatomy and pathophysiology of facial aging. Facial Plast Surg Clin North Am. 2001;9:179-187. vii
3. Glaser DA, Rogers C. Topical and systemic therapies for the aging face. Facial Plast Surg Clin North Am. 2001;9:189-196. vii
4. Bitter PH. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg. 2000;26:835-842; discussion 843.
5. Freeman MS. Microdermabrasion. Facial Plast Surg Clin North Am. 2001;9:257-266. viii
6. Alam M, Omura NE, Dover JS, et al. Glycolic acid peels compared to microdermabrasion: A right-left controlled trial of efficacy and patient satisfaction. Dermatol Surg. 2002;28:475-479.
7. Ratner D, Tse Y, Marchell N, et al. Cutaneous laser resurfacing. J Am Acad Dermatol. 1999;41:365-389; quiz 390-362.
8. Tsui JK. Botulinum toxin as a therapeutic agent. Pharmacol Ther. 1996;72:13-24.
9. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43:249-259.
10. Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol. 1973;12:924-927.
11. Bentley C. Botulinum neurotoxin A in ophthalmology. Ophthalmic Physiol Opt. 1996;16 (suppl 1):S9-14.
12. Osako M, Keltner JL. Botulinum A toxin (Oculinum) in ophthalmology. Surv Ophthalmol. 1991;36:28-46.
13. Matarasso SL. Comparison of botulinum toxin types A and B: A bilateral and double-blind randomized evaluation in the treatment of canthal rhytides. Dermatol Surg. 2003;29:7-13; discussion 13.
14. Borodic GE, Pearce LB, Cheney M, et al. Botulinum A toxin for treatment of aberrant facial nerve regeneration. Plast Reconstr Surg. 1993;91:1042-1045.
15. Riemann R, Pfennigsdorf S, Riemann E, et al. Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland: A case report. Ophthalmology. 1999;106:2322-2324.
16. O'Day J. Use of botulinum toxin in neuro-ophthalmology. Curr Opin Ophthalmol. 2001;12:419-422.
17. Blitzer A, Binder WJ. Current practices in the use of botulinum toxin A in the management of facial lines and wrinkles. Facial Plast Surg Clin North Am. 2001;9:395-404.
18. Carruthers A. Botulinum toxin type A: History and current cosmetic use in the upper face. Dis Mon. 2002;48:299-322.
19. Carter SR, Seiff SR. Cosmetic botulinum toxin injections. Int Ophthalmol Clin. 1997;37:69-79.
20. Carruthers J, Carruthers A. Botulinum toxin (botox) chemodenervation for facial rejuvenation. Facial Plast Surg Clin North Am. 2001;9:197-204. vii
21. Alam M, Dover JS, Arndt KA. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: A double-blind, randomized controlled trial. Arch Dermatol. 2002;138:510-514.
22. Mohan M, Fleck BW. Globe perforation during botulinum toxin injection. Br J Ophthalmol. 1999;83:503-504.
23. Matarasso SL. Decreased tear expression with an abnormal Schirmer's test following botulinum toxin type A for the treatment of lateral canthal rhytides. Dermatol Surg. 2002;28:149-152.
24. Sanders DB, Massey EW, Buckley EG. Botulinum toxin for blepharospasm: Single-fiber EMG studies. Neurology. 1986;36:545-547.
25. Alam M, Arndt KA, Dover JS. Severe, intractable headache after injection with botulinum a exotoxin: Report of 5 cases. J Am Acad Dermatol. 2002;46:62-65.
26. Goschel H, Wohlfarth K, Frevert J, et al. Botulinum A toxin therapy: Neutralizing and nonneutralizing antibodies-therapeutic consequences. Exp Neurol. 1997;147:96-102.
27. Latimer PR, Hodgkins PR, Vakalis AN, et al. Necrotising fasciitis as a complication of botulinum toxin injection. Eye. 1998;12:51-53.
28. Sloop RR, Cole BA, Escutin RO. Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use. Neurology. 1997;48:249-253.
29. Gartlan MG, Hoffman HT. Crystalline preparation of botulinum toxin type A (Botox): Degradation in potency with storage. Otolaryngol Head Neck Surg. 1993;108:135-140.
30. Patient Alert. American Academy of Dermatology Stresses the Safe Use of Botulinum Toxin. Report issued by the American Academy of Dermatology. 2002;April:30. Schaumburg, IL.
31. Maas CS, Denton AB. Synthetic soft tissue substitutes: 2001. Facial Plast Surg Clin North Am. 2001;9:219-227. viii
32. Ellis DA, Makdessian AS, Brown DJ. Survey of future injectables. Facial Plast Surg Clin North Am. 2001;9:405-411.
33. Klein AW. Collagen substances. Facial Plast Surg Clin North Am. 2001;9:205-218. viii
34. Mak K, Toriumi DM. Injectable filler materials for soft-tissue augmentation. Otolaryngol Clin North Am. 1994;27:211-222.
35. Sclafani AP, Romo T 3rd. Injectable fillers for facial soft tissue enhancement. Facial Plast Surg. 2000;16:29-34.
36. Alster TS, West TB. Human-derived and new synthetic injectable materials for soft-tissue augmentation: Current status and role in cosmetic surgery. Plast Reconstr Surg. 2000;105:2515-2525; discussion 2526-2528
37. Shiffman MA, Kaminski MV. Fat transfer to the face: Technique and new concepts. Facial Plast Surg Clin North Am. 2001;9:229-237. viii
38. Boss WK Jr, Usal H, Fodor PB, et al. Autologous cultured fibroblasts: A protein repair system. Ann Plast Surg. 2000;44:536-542.
39. Watson D, Keller GS, Lacombe V, et al. Autologous fibroblasts for treatment of facial rhytids and dermal depressions. A pilot study. Arch Facial Plast Surg. 1999;1:165-170.
40. Shafir R, Amir A, Gur E. Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg. 2000;106:1215-1216.
41. Cooperman L, Michaeli D. The immunogenicity of injectable collagen: II. A retrospective review of seventy-two tested and treated patients. J Am Acad Dermatol. 1984;10:647-651.
42. Kamer FM, Churukian MM. Clinical use of injectable collagen. A three-year retrospective review. Arch Otolaryngol. 1984;110:93-98.
43. Cooperman LS, Mackinnon V, Bechler G, et al. Injectable collagen: A six-year clinical investigation. Aesthetic Plast Surg. 1985;9:145-151.
44. Lowe NJ, Maxwell CA, Lowe P, et al. Hyaluronic acid skin fillers: Adverse reactions and skin testing. J Am Acad Dermatol. 2001;45:930-933.
45. Shin H, Lemke BN, Stevens TS, et al. Posterior ciliary-artery occlusion after subcutaneous silicone-oil injection. Ann Ophthalmol. 1988;20:342-344.
46. Egbert JE, Schwartz GS, Walsh AW. Diagnosis and treatment of an ophthalmic artery occlusion during an intralesional injection of corticosteroid into an eyelid capillary hemangioma. Am J Ophthalmol. 1996;121:638-642.
47. Selmanowitz VJ, Orentreich N. Cutaneous corticosteroid injection and amaurosis. Analysis for cause and prevention. Arch Dermatol. 1974;110:729-734.
48. Schanz S, Schippert W, Ulmer A, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol. 2002;146:928-929.